
Because of the global rise in antimicrobial resistance, meropenem-vaborbactam, the first carbapenem/β-lactamase combina­tion medication, is a welcome new antibac­terial.

Because of the global rise in antimicrobial resistance, meropenem-vaborbactam, the first carbapenem/β-lactamase combina­tion medication, is a welcome new antibac­terial.

Given the impressive efficacy of fecal microbiota transplantation (FMT) on decreasing recurrence of Clostridium difficile infection (CDI), the next logical step is seeing how it works for hospitalized patients with CDI.

For all you last-minute shoppers, Payal K. Patel MD, MPH, and Sujit Suchindran MD, have put together a wish list of the top items to get the infectious disease physician in your life.

Published: December 22nd 2017 | Updated:

Published: April 10th 2018 | Updated:

Published: June 28th 2018 | Updated: